Tectonic Therapeutic Target Price

Analysts' average 12-month price target for Tectonic Therapeutic is $53.

Get informed when a big investor buys or sells

+ Follow

Share Price

$21.14

Average Target Price

$53.00

150.7% upside

2 analysts in the last 4 months

High: $80 | Low: $26

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-10-11	UBSAlice Nettleton	$26	23% upside
2026-09-30	OppenheimerLeland Gershell	$80	278.4% upside
2026-05-26	Raymond JamesMartin Auster	$81	283.2% upside
2026-04-13	Stifel Nicolaus	$75	254.8% upside
2026-01-08	Truist FinancialDanielle Brill	$60	183.8% upside

Tectonic Therapeutic (TECX) FAQ

The latest target price for TECX is $53. Investors often review this figure alongside Tectonic Therapeutic's historical trend and sector peers before judging valuation or financial health.

Tectonic Therapeutic trades near $21.14 while the consensus target sits at $53 (150.7% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting TECX's target price ($53), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.